NZ542151A - Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments - Google Patents

Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments

Info

Publication number
NZ542151A
NZ542151A NZ542151A NZ54215104A NZ542151A NZ 542151 A NZ542151 A NZ 542151A NZ 542151 A NZ542151 A NZ 542151A NZ 54215104 A NZ54215104 A NZ 54215104A NZ 542151 A NZ542151 A NZ 542151A
Authority
NZ
New Zealand
Prior art keywords
alkaloid
chelidonine
derivative
present
process according
Prior art date
Application number
NZ542151A
Other languages
English (en)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of NZ542151A publication Critical patent/NZ542151A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564—Three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
NZ542151A 2003-03-18 2004-03-12 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments NZ542151A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03006015A EP1459753A1 (en) 2003-03-18 2003-03-18 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
PCT/EP2004/002637 WO2004082698A1 (en) 2003-03-18 2004-03-12 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments

Publications (1)

Publication Number Publication Date
NZ542151A true NZ542151A (en) 2008-11-28

Family

ID=32798820

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ542151A NZ542151A (en) 2003-03-18 2004-03-12 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments

Country Status (36)

Country Link
US (1) US7795434B2 (enExample)
EP (2) EP1459753A1 (enExample)
JP (1) JP5303719B2 (enExample)
KR (1) KR101020680B1 (enExample)
CN (1) CN1532198A (enExample)
AR (1) AR043629A1 (enExample)
AT (1) ATE469651T1 (enExample)
AU (1) AU2004222661B2 (enExample)
BR (1) BRPI0408386A (enExample)
CA (1) CA2517769C (enExample)
CL (2) CL2004000552A1 (enExample)
CY (1) CY1112598T1 (enExample)
DE (1) DE602004027496D1 (enExample)
DK (1) DK1644012T3 (enExample)
EA (1) EA009049B1 (enExample)
ES (1) ES2346216T3 (enExample)
GE (1) GEP20084501B (enExample)
GT (1) GT200400046A (enExample)
HR (1) HRP20050987B1 (enExample)
IL (1) IL170505A (enExample)
MA (1) MA27833A1 (enExample)
MX (1) MXPA05009919A (enExample)
MY (1) MY141779A (enExample)
NO (1) NO333672B1 (enExample)
NZ (1) NZ542151A (enExample)
PA (1) PA8598201A1 (enExample)
PE (1) PE20050351A1 (enExample)
PL (1) PL1644012T3 (enExample)
PT (1) PT1644012E (enExample)
SG (1) SG158748A1 (enExample)
SI (1) SI1644012T1 (enExample)
TN (1) TNSN05230A1 (enExample)
TW (1) TWI347939B (enExample)
UA (1) UA89353C2 (enExample)
WO (1) WO2004082698A1 (enExample)
ZA (1) ZA200507020B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
WO2009148623A2 (en) 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer
CN102552264A (zh) * 2012-02-28 2012-07-11 苏州大学 血根碱在制备电离辐射防护剂中的应用
WO2021073603A1 (en) * 2019-10-17 2021-04-22 Chengdu Anticancer Bioscience, Ltd. Benzophenanthridine alkaloids and their methods of use
CN113372355B (zh) * 2021-05-13 2023-02-17 山东大学 六氢苯并菲啶类生物碱及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865830A (en) 1969-06-16 1975-02-11 Nikolai Mikhailovich Turkevich Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
SU368254A1 (ru) 1969-06-16 1973-01-26 А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт Способ получения соединений тиофосфамида с алкалоидами чистотела большого
AT354644B (de) 1975-12-19 1980-01-25 Nowicky Wassili Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) 1976-06-28 1985-05-28 Nowicky Wassili Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de) 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407833B (de) * 1995-06-01 2001-06-25 Nowicky Wassyl Dr Mittel zur behandlung von strahlenschäden
AT408719B (de) 2000-03-22 2002-02-25 Nowicky Wassili Mittel zur behandlung von hepatitis c
CH695417A5 (de) 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.

Also Published As

Publication number Publication date
TNSN05230A1 (en) 2007-06-11
NO20054130D0 (no) 2005-09-06
CA2517769A1 (en) 2004-09-30
CL2004000552A1 (es) 2005-01-21
GT200400046A (es) 2005-11-24
US7795434B2 (en) 2010-09-14
EP1644012B1 (en) 2010-06-02
NO333672B1 (no) 2013-08-05
EA200501473A1 (ru) 2006-02-24
TW200505467A (en) 2005-02-16
JP5303719B2 (ja) 2013-10-02
AR043629A1 (es) 2005-08-03
GEP20084501B (en) 2008-10-10
JP2006520763A (ja) 2006-09-14
EP1644012A1 (en) 2006-04-12
PA8598201A1 (es) 2004-11-26
US20060154947A1 (en) 2006-07-13
DE602004027496D1 (de) 2010-07-15
AU2004222661A1 (en) 2004-09-30
MY141779A (en) 2010-06-30
UA89353C2 (uk) 2010-01-25
CY1112598T1 (el) 2016-02-10
PL1644012T3 (pl) 2011-01-31
PE20050351A1 (es) 2005-05-04
DK1644012T3 (da) 2010-10-04
ATE469651T1 (de) 2010-06-15
EP1459753A1 (en) 2004-09-22
BRPI0408386A (pt) 2006-03-21
AU2004222661B2 (en) 2008-10-02
KR20060010726A (ko) 2006-02-02
KR101020680B1 (ko) 2011-03-09
HRP20050987A2 (en) 2007-07-31
CL2008002345A1 (es) 2009-01-02
TWI347939B (en) 2011-09-01
CA2517769C (en) 2012-09-25
ZA200507020B (en) 2006-11-29
CN1532198A (zh) 2004-09-29
HRP20050987B1 (hr) 2014-03-28
NO20054130L (no) 2005-12-19
EA009049B1 (ru) 2007-10-26
WO2004082698A1 (en) 2004-09-30
SI1644012T1 (sl) 2010-10-29
MA27833A1 (fr) 2006-04-03
IL170505A (en) 2013-04-30
PT1644012E (pt) 2010-07-29
ES2346216T3 (es) 2010-10-13
MXPA05009919A (es) 2006-03-21
SG158748A1 (en) 2010-02-26

Similar Documents

Publication Publication Date Title
CA2386775C (en) Drugs for the treatment of malignant tumours
US4970212A (en) Method of treating human illnesses which compromise the ability to mount an effective immunological response
GB2110533A (en) Compositions containing alkaloid derivatives
CA2517769C (en) Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
CN111349092B (zh) 一种线粒体靶向化合物及其制备方法和应用
RU2120939C1 (ru) 6-[x-(2-гидроксиэтил)аминоалкил]-5,11-диоксо-5,6-дигидро-11h-инде- но/1,2-с/изохинолины или их соли с неорганическими и органическими кислотами, способы их получения и фармацевтическая композиция на их основе
CA2593202A1 (en) Quaternary alkaloid derivatives of chelidonium majus l
WO2012075957A1 (zh) 咖啡酸苯乙酯类衍生物在制备抗肿瘤血管形成的药物中的用途
JP2006520763A5 (enExample)
US6197767B1 (en) Arglabin compounds and therapeutic uses thereof
CN116589502B (zh) 一种四价铂类免疫原性死亡诱导剂及其制备方法与应用
EP0996441A1 (en) Pharmaceutical compositions of arglabin and arglabin derivatives
FI75802C (fi) Foerfarande foer framstaellning av saosom immunostimulerande aemnen anvaendbara bis- och polydisulfider.
US7732485B2 (en) Treatment of cancer
JP2005509006A (ja) アルカロイドを反応させる製造方法および反応生成物の薬剤調製の使用
JP2002535276A (ja) ４−デメチルペンクロメジンのアシル誘導体、その使用及び調製
CN118976022A (zh) 桑辛素的抗淋巴瘤用途
US20040116385A1 (en) Treating and preventing viral infections with porphyrin-based compounds
CN120682279A (zh) 一种具有光动力断裂DNA能力的ICD诱导剂Ru(II) 配合物及其制备方法和应用
KR0169805B1 (ko) 알로에신을 함유하는 세포성장 촉진제 조성물
CN118307712A (zh) 一种用于硼中子捕获疗法的新的含硼聚合物
EP3337466A1 (en) Novel polygodial analogs for the treatment of cancer and other proliferative diseases

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 MAR 2017 BY EUROPEAN PATENT ANNUITY SERVICE GMBH

Effective date: 20140226

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAR 2018 BY EUROPEAN PATENT ANNUITY SERVICE GMBH

Effective date: 20170222

LAPS Patent lapsed